Advertisement

Topics

iNova Pharmaceuticals Company Profile

03:17 EDT 19th October 2017 | BioPortfolio

iNova Pharmaceuticals (Australia) Pty Limited is an Australian owned and operated pharmaceutical company that is the corporate headquarters for iNova Pharmaceuticals (“iNova”) operations. iNova has leading consumer healthcare and specialty prescription brands in over 15 countries, including Australia, New Zealand, Asia Pacific and Africa regions. The company’s product portfolio includes in-licensed and in-house developed drugs in weight management, pain management, allergy, sexual health, dermatology, cardiology and respiratory health.

Borne out of more than 50 years heritage from Riker Laboratories and 3M Pharmaceuticals following the November 2006 purchase of 3M’s Asia-Pacific pharmaceutical business by Australian private equity firms Archer Capital and Ironbridge Capital, iNova has a broad spectrum of capabilities to extend product brands into new and existing markets. These include high quality sales and marketing execution, in-licensing, developing and acquiring products, alongside manufacturing, quality and regulatory processes.

In addition to its own dedicated business enterprises, iNova is a collaborator that works in partnership with external parties. These include sales and marketing business partners and pharmaceutical companies in other countries to make products available to the broader global community. iNova is able to successfully launch products (licensed-in or developed in-house) throughout southeast Asia and South Africa in Australia and New Zealand and also exports to countries such as Japan, Korea and China.

Fundamental to iNova’s future product pipeline are new opportunities bringing patient and consumer value in selected therapy areas. With its flexibility, established infrastructure and proven track record, iNova is an attractive licensing partner for companies planning to enter the Asia-Pacific and Africa regions.

Location

iNova Pharmaceuticals (Australia) Pty Limited
9 – 15 Chilvers Road
Thornleigh
NSW
2120
Australia

Contact

Phone: + 61 2 9875 6322
Fax: + 61 2 9875 6416


News Articles [494 Associated News Articles listed on BioPortfolio]

Valeant to sell its iNova unit for $930m

Embattled Canadian drugmaker Valeant Pharmaceuticals said on Thursday it would sell its iNova Pharmaceuticals business for $930 million in cash as it looks to pay down debt.

Valeant Pharmaceuticals to sell iNova business for $930m

Canadian company Valeant Pharmaceuticals International has entered an agreement to divest its iNova Pharmaceuticals business for $930m.

Valeant is selling its iNova Pharmaceuticals business for $930 million

Valeant Pharmaceuticals International Inc said it would sell its iNova Pharmaceuticals business for $930 million, as Chief Executive Officer Joseph Papa steps up efforts to slash the embattled Canadia...

Valeant to sell iNova Pharma for $930M

Pacific Equity Partners and The Carlyle Group will pay $930 million to acquire Valeant's iNova Pharmaceuticals business.  -More- 

Valeant to divest iNova Pharmaceuticals for $930m

Valeant Pharmaceuticals International has agreed to divest its iNova Pharmaceuticals business for around $930m.

Valeant Selling iNova to Private Equity for $930 Million

Canada-based, US-run drugmaker Valeant has agreed to sell its iNova Pharmaceuticals subsidiary for $930 million in cash to a company jointly owned by funds advised and managed by Pacific Equity Partne...

Valeant to divest iNova Pharmaceuticals for $930 million

Troubled Canadian drugmaker Valeant Pharmaceuticals International has entered into an agreement to sell…

Valeant Agrees to Sell iNova Pharma Business to Carlyle and Pacific Equity for $930M

Valeant has agreed the $930 million sale of its iNova Pharmaceuticals business to a company owned jointly by fund managers Pacific Equity Partners and The Carlyle Group. Valeant says it will use proce...

PubMed Articles [127 Associated PubMed Articles listed on BioPortfolio]

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Comparative study on pharmaceuticals adsorption in reclaimed water desalination concentrate using biochar: Impact of salts and organic matter.

The synergistic impact of salts and organic matter on adsorption of ibuprofen and sulfamethoxazole by three types of biochar and an activated carbon was investigated using reclaimed water reverse osmo...

Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka.

Antibiotics and antidepressants are among the most successful drugs used for human therapy. Their concentration in influent on WWTP is relative high and there can be removed by biodegradation or sorpt...

Clinical Trials [207 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Flourishing App: Evaluation of the Effectiveness of a Well-being Application for Mobile Devices

This protocol proposes a well-being program, delivered through an application for mobile devices, based on meditation and positive psychology principles such as human development, the impr...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Companies [1291 Associated Companies listed on BioPortfolio]

Inova Software Inc.

Inova Software, Inc. is the leading innovation software solutions provider. Our full range of products helps you source, enrich and manage innovative ideas through a software platform. Thus your com...

Focus Bio-Inova, Inc

Focus Bio-Inova provides global central laboratory and custom microbiology services to help biopharmaceutical researchers expedite the discovery, development and commercialization of new therapeutics....

iNova Pharmaceuticals

iNova Pharmaceuticals (Australia) Pty Limited is an Australian owned and operated pharmaceutical company that is the corporate headquarters for iNova Pharmaceuticals (“iNova”) operations. iNova ha...

INOVA Diagnostics, Inc

INOVA Diagnostics, Inc. was formed in 1987 by a group of scientists—drawn from the academic, clinical and industrial communities but united by one common interest... Autoimmune Disease Diagnostic Te...

Inova Diagnostics Inc

Our Mission Our single focus allows us to offer you unmatched quality, reliable consistency, and excellent value on the most comprehensive range of autoimmune testing reagents available anywhere. Our ...

More Information about "iNova Pharmaceuticals" on BioPortfolio

We have published hundreds of iNova Pharmaceuticals news stories on BioPortfolio along with dozens of iNova Pharmaceuticals Clinical Trials and PubMed Articles about iNova Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of iNova Pharmaceuticals Companies in our database. You can also find out about relevant iNova Pharmaceuticals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...


Corporate Database Quicklinks



Searches Linking to this Company Record